Curexa Pharmacy has received full accreditation status from the Utilization Review Accreditation Commission (URAC) due to its specialty pharmacy services. Read More »

CVS Health announced last week that its EVP and CFO, Dave Denton, will address investors at the Cowen and Co. 36th Annual Health Care Conference. Read More »

Dan Durham, the EVP for Health Policy of the Biotechnology Innovation Organization (BIO), has released a statement in response to the White House’s announcement about its intent to fast-track the Precision Medicine Initiative. Read More »

GenSight Biologics S.A. announced this week that the first patient has enrolled in the company’s two parallel Phase 3 trials for GS010, a medicine designed to treat Leber’s Hereditary Optic Neuropathy (LHON). Read More »

Aldeyra Therapeutics Inc. has reported that its Phase 2a clinical trial of topical ocular NS2 has shown positive results. Read More »

Generic Pharmaceutical Association (GPhA) CEO and President Chip Davis stated in a recent press release that generic drug savings were imperative to long-term solutions to rising health costs and explained that the focus should be on increasing pharmaceutical competition and expanding access to safe, effective and more affordable generic drugs. Read More »